Moderna Shares More Than Double on Success of mRNA Cancer Vaccine
Analog Devices reports surging AI data center demand; SK Hynix allocates $28B to capacity expansion, and Unitree Robotics debuts humanoid robots in mainland China. AI infrastructure capex is accelerating globally; managers should anticipate chip supply tightness and competitive pressure from Asian players.
Moderna Shares More Than Double on Success of mRNA Cancer Vaccine
The results from a Merck-Moderna partnership validate years of research into a new approach to cancer treatment.
OpenAI's Latest Bid to Fight Anthropic: A Promise Not to Keep Customer Data
The ChatGPT maker hopes to win business customers who are upset that Anthropic is keeping their data.
Target Raises Fiscal-Year Forecast Again as Turnaround Gains Traction
Moderna Shares More Than Double on Success of mRNA Cancer Vaccine
Moderna Shares More Than Double on Success of mRNA Cancer Vaccine
Moderna Shares Double on Success of mRNA Cancer Vaccine
Analysts pointed to an upcoming health care conference and cancer data study release as potential catalysts for Moderna's ongoing…
Moderna shares surged after positive Phase 3 results for its Merck-partnered melanoma cancer vaccine, boosting confidence in its…
The results come at a pivotal moment for Moderna and mRNA research.
Moderna's and Merck's personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in late stage trial and sends stocks soaring | Fortune
